ED-LP03-10 · ED-LP03
Help donors understand why a cycle may be adjusted or cancelled and prepare for the practical and emotional impact without self-blame. Useful education keeps donor autonomy, bodily risk, privacy, practical burden and future implications visible at the same time.
Visual lesson summary
Review the lesson as a carousel.
Swipe or scroll through the key ideas, then continue with the detailed guidance below.
01 / 06Under-Response, Over-Response, and Cancellation 
02 / 06Why this matters 
03 / 06How the process should work 
04 / 06How to read the evidence 
05 / 06What the donor decides 
06 / 06Keep donor choice visible
Keep the donor at the centre
Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps. The donor remains the person whose health information, body, consent, time and privacy are involved. Program eligibility is not consent, recipient preference is not clinical authority, and compensation does not transfer decision ownership. Start by identifying the exact decision, the donor's options and the professional accountable for explaining the evidence.
For under-response, over-response, and cancellation, the concrete checkpoints include under-response, over-response, cancellation, define, inadequate. The donor should be able to ask privately what each checkpoint can change, what it cannot predict, who sees the information and what happens after a pause or disagreement. Written answers should match the documents and current jurisdiction.
Donor checkpoint for under-response, over-response, and cancellation: obtain the complete cohort, record its date and accountable owner, and keep its interpretation limit beside the next action. If policy or law changes the answer, ask for the named jurisdiction, effective date, and independent review route rather than relying on a verbal summary.
Why this changes informed choice
Biological variability can override preparation, and cancellation may protect safety or reflect low expected benefit rather than donor failure. A donor-centred process does not ask whether a reader is cooperative enough to proceed. It asks whether information is complete, pressure is absent, practical burdens are visible and a pause can be expressed without retaliation. Acceptance by one program is not a certificate of health or worth; a decline is not a diagnosis unless an appropriate clinician explains a finding separately.
For under-response, over-response, and cancellation, the concrete checkpoints include over-response, cancellation, define, inadequate, excessive. The donor should be able to ask privately what each checkpoint can change, what it cannot predict, who sees the information and what happens after a pause or disagreement. Written answers should match the documents and current jurisdiction.
Donor checkpoint for under-response, over-response, and cancellation: obtain the complete monitoring trend, record its date and accountable owner, and keep its interpretation limit beside the next action. If policy or law changes the answer, ask for the named jurisdiction, effective date, and independent review route rather than relying on a verbal summary.
How the process should be documented
Show how teams integrate trends, symptoms, protocol goals, and consent; require explanation of medicines, follow-up, payment, and future eligibility. Put the sequence in writing. Record the applicable policy or protocol version, responsible entity, appointment or document, information collected, possible result categories, privacy route, decision point and escalation contact. Separate a clinic's medical role, an agency's coordination role, an independent adviser's role and the donor's continuing participation decision.
Donor checkpoint for under-response, over-response, and cancellation: obtain the complete trigger instruction, record its date and accountable owner, and keep its interpretation limit beside the next action. If policy or law changes the answer, ask for the named jurisdiction, effective date, and independent review route rather than relying on a verbal summary.
Read evidence without overclaiming
Stimulation decisions for under-response, over-response, and cancellation depend on trends rather than a single isolated number. Review under-response, over-response, cancellation, response, distributions with symptoms, protocol goals, collection timing, and the treating clinician's documented interpretation. A monitoring value can support a dose change, trigger choice, additional review, or cancellation discussion without predicting egg number or outcome. Preserve the reason for every change and the donor's continuing right to ask questions or stop.
Make risk and escalation usable
The safety plan for under-response, over-response, and cancellation must distinguish expected effects, symptoms requiring same-day clinic contact, and signs requiring urgent or emergency assessment. It should name a 24-hour contact, backup service, medication instructions, travel restrictions where relevant, coverage for unplanned care, and follow-up after cancellation or retrieval. Reassurance without a reachable escalation route is not adequate risk communication.
Protect privacy and future records
For under-response, over-response, and cancellation, medication logs, ultrasound and laboratory trends, symptoms, cancellation reasons, and communications form part of the donor's health record. Clarify who receives those updates, what a recipient is told, what remains confidential, how portal access ends, and how the donor obtains a complete cycle summary. Operational convenience does not justify sharing more health information than the relevant role needs.
Build a decision record
Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed. Make the next step reversible where possible. Keep copies of the relevant forms and answers, mark unresolved questions, name the independent reviewer and define a stopping condition. The following remain outside this lesson: Contract-specific payment entitlement; Detailed OHSS management; Repeat-donation decisions. Route those questions rather than allowing a broad assurance to stand in for clinical, legal, genetic or psychological review.
- Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.
- Ask who owns the decision and who only advises.
- Request the current document, protocol or policy version.
- Record privacy, cost, escalation and stopping arrangements.
For Nerds: Technical Deep Dive
Cover response distributions, cohort synchrony, OHSS risk prediction, diminishing expected yield, cancellation thresholds, and limits of retrospective certainty.
Mechanism, burden and donor safety
A defensible technical record for under-response, over-response, and cancellation starts with under-response, over-response, cancellation, response, distributions, cohort, medication teaching record, dose and timing log, monitoring trend, symptom escalation route, trigger instruction, cycle change record. Each item needs a stable claim or document identifier, source authority, date, method or legal basis, applicable population or jurisdiction, accountable interpreter, access rule, and an explicit limit. Cover response distributions, cohort synchrony, OHSS risk prediction, diminishing expected yield, cancellation thresholds, and limits of retrospective certainty. The donor-facing implication must remain separate from recruitment, recipient preference, and program convenience. Program eligibility cannot substitute for consent, and a signed consent cannot cure missing risk information, coercion, unclear data use, or an absent escalation route. Evidence review should compare authority, applicability, completeness, conflicts, and uncertainty. Current source set: ESHRE ovarian stimulation guideline; ASRM OHSS prevention guideline; ASRM donation guidance; ACOG informed consent and shared decision making. A professional guideline may describe recommended practice; a regulator may establish a minimum; a clinic policy may be narrower; and a personal clinical or legal opinion depends on individual facts. Do not turn a population association into an individual prediction, a program threshold into a diagnosis, or a jurisdiction example into a universal rule. Record missing denominators, assay or observer variation, sampling limits, selection bias, incomplete follow-up, changing law, and which reviewer must resolve the uncertainty.
- Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps.
- Show how teams integrate trends, symptoms, protocol goals, and consent; require explanation of medicines, follow-up, payment, and future eligibility.
- Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.
Expected ranges / examples
- Donor decision sequence: under-response -> over-response -> cancellation -> define -> inadequate. A non-numeric example showing why screening, consent, treatment and outcome labels must remain distinct. Source: ESHRE ovarian stimulation guideline.
Measures, policies and uncertainty
Operationalize autonomy with a responsibility matrix and a stop-point log. The donor controls participation and personal consent; clinicians control diagnosis and treatment recommendations; laboratories control validated methods and reports; genetic professionals interpret genetic findings; independent counsel advises the donor on legal consequences; and coordinators manage handoffs without absorbing those authorities. Record which action is optional, what happens after a pause or withdrawal, what care and payment remain due, how privacy is protected, and who handles urgent and non-urgent concerns. Compensation must never be described as purchasing eggs, compliance, medical risk, silence, identity rights, or future contact. Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed. Build the decision record with the exact question, supporting records, unresolved conditions, professional owner, source date, donor preference, other participants' separate rights, and a trigger to proceed, proceed conditionally, pause, seek review, or stop. Test the proposed action against the exclusions: Contract-specific payment entitlement; Detailed OHSS management; Repeat-donation decisions. Those boundaries prevent this package from drifting into diagnosis, prescribing, contract drafting, outcome prediction, or relationship promises. The technical layer supports better questions; it does not make the decision for the donor.
- Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps.
- Show how teams integrate trends, symptoms, protocol goals, and consent; require explanation of medicines, follow-up, payment, and future eligibility.
- Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.
Expected ranges / examples
- Donor decision sequence: over-response -> cancellation -> define -> inadequate -> excessive. A non-numeric example showing why screening, consent, treatment and outcome labels must remain distinct. Source: ESHRE ovarian stimulation guideline.
Consent, privacy and decision limits
Evidence review should compare authority, applicability, completeness, conflicts, and uncertainty. Current source set: ESHRE ovarian stimulation guideline; ASRM OHSS prevention guideline; ASRM donation guidance; ACOG informed consent and shared decision making. A professional guideline may describe recommended practice; a regulator may establish a minimum; a clinic policy may be narrower; and a personal clinical or legal opinion depends on individual facts. Do not turn a population association into an individual prediction, a program threshold into a diagnosis, or a jurisdiction example into a universal rule. Record missing denominators, assay or observer variation, sampling limits, selection bias, incomplete follow-up, changing law, and which reviewer must resolve the uncertainty. Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed. Build the decision record with the exact question, supporting records, unresolved conditions, professional owner, source date, donor preference, other participants' separate rights, and a trigger to proceed, proceed conditionally, pause, seek review, or stop. Test the proposed action against the exclusions: Contract-specific payment entitlement; Detailed OHSS management; Repeat-donation decisions. Those boundaries prevent this package from drifting into diagnosis, prescribing, contract drafting, outcome prediction, or relationship promises. The technical layer supports better questions; it does not make the decision for the donor.
- Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps.
- Show how teams integrate trends, symptoms, protocol goals, and consent; require explanation of medicines, follow-up, payment, and future eligibility.
- Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.
Key takeaways
- Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps.
- Biological variability can override preparation, and cancellation may protect safety or reflect low expected benefit rather than donor failure.
- Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.
- A donor can ask questions, seek independent advice, pause or decline without being reduced to a program outcome.
FAQ
What does under-response, over-response, and cancellation mean for a donor?
Define inadequate, excessive, asynchronous, or otherwise concerning response; clinical adjustments; cancellation; and communication of next steps.
Why does this matter before proceeding?
Biological variability can override preparation, and cancellation may protect safety or reflect low expected benefit rather than donor failure.
How should the process work?
Show how teams integrate trends, symptoms, protocol goals, and consent; require explanation of medicines, follow-up, payment, and future eligibility.
Can a program decision replace my consent?
No. Eligibility, coordination and clinical recommendations are different from the donor’s voluntary and continuing participation decision.
Which review lenses are required?
The approved scope requires editorial, medical, quantitative, psychological; each reviewer owns a distinct accuracy and safety question.
What should I record before deciding?
Whether to accept adjustment, ask for clarification, stop the cycle, and what follow-up or independent support is needed.